CA
NZ
UK
AU
IND
US
Johnson & Johnson (NYSE:JNJ) is a diversified healthcare group with an innovative medicines business and a medical technology unit. It reports on October 13, 2026, and published estimates point to EPS near USD 2.51 on revenue close to USD 25.4 billion. Pharmaceutical sales, including …
When a stock joins the Nasdaq-100, funds that track the index must buy it so their holdings match. Invesco QQQ Trust (NASDAQ:QQQ) and similar funds hold billions of dollars that follow this index, so inclusion creates demand that does not depend on company news. …
Novavax (NASDAQ:NVAX) rose about 16% on October 9, 2026 and closed near USD 12.77, based on published market data. The company released no news that day in the information reviewed, and no filing, trial result or partner announcement was found. The cause is unknown, …
Ginkgo Bioworks (NYSE:DNA) operates a platform that designs and builds engineered cells and organisms for customers in pharmaceuticals, agriculture and industrial chemistry. The company has a history of heavy losses and large swings in its share price, which makes it a common vehicle for …
Quantum-Si (NASDAQ:QSI) rose 25% on October 9, 2026, ranking as the largest gainer among exchange-listed names that day in published market data. Researchers searched for a reason and found none: there was no earnings release, no regulatory event, no partnership and no analyst note …
● CUE closed Friday, October 9, 2026, at $28.00, up 25.39%, adding roughly a quarter to its prior value.
● DFTX closed Friday, October 9, 2026, at $36.90, up 7.96%, among the stronger US gainers of the session.
● Cash and securities were $285.2 million at April 30, after a roughly 50% workforce reduction.
● Second-quarterRevenuerose to $652.5 million from $444.3 million, driven by the company's Performance Suite.
● HIMS closed Friday, October 9, 2026, at $30.92, up 10.19%, among the session’s stronger performers.
Please wait processing your request...